Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Lan Su

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Scientific Reports|March 1, 2022
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapyPo-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Therapeutic Advances in Medical Oncology|June 7, 2021
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 studyYen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, et al.
Cancer Medicine|July 28, 2025
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based TherapiesMingjia Li, Po-Lan Su, Songzhu Zhao, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Scientific Reports|March 1, 2022
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapyPo-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Therapeutic Advances in Medical Oncology|June 7, 2021
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 studyYen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, et al.
Cancer Medicine|July 28, 2025
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based TherapiesMingjia Li, Po-Lan Su, Songzhu Zhao, et al.
Pageof 7